Hebei Yanda Hospital
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of IDH1R132H-DC Vaccine in Gliomas (NCT02771301) | Hebei Yanda Hospital | 2016-02-01 |
| Ultra-low Dose Bevacizumab Plus Temozolomide for Recurrent High-grade Gliomas (NCT02416999) | Hebei Yanda Hospital | 2015-05-01 |
| A Study to Evaluate the Safety and Effectiveness of PCV Chemotherapy in Patients With Recurrent High-grade Glioma With IDH1/2 Mutation (NCT02333513) | Hebei Yanda Hospital | 2015-02-01 |
Track Hebei Yanda Hospital automatically
Every clearance here is in the API, with alerts when new ones post.